What is NDC 70069-876?

70069-876 is the product NDC for Nicardipine Hydrochloride, Nicardipine hydrochloride .2 mg/mL injection, listed with the FDA by Somerset Therapeutics, LLC. It has 1 package NDC, shown above in 10- and 11-digit form.

Somerset Therapeutics, LLC, NDC labeler code 70069. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Nicardipine Hydrochloride?

43 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Nicardipine Hydrochloride NDC 70069-876

NDC codes

FDA NDC Directory

Product NDC (as listed)70069-876Labeler and product segments. Claims need a package NDC.

Product NDC at billing width70069-0876Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
70069-876-10	7006908761070069087610	10 POUCH in 1 CASE (70069-876-10) / 1 BAG in 1 POUCH (70069-876-01) / 200 mL in 1 BAGMarketed from Apr 20, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Nicardipine Hydrochloride
Generic name (nonproprietary): nicardipine hydrochloride
Active ingredients: Nicardipine hydrochloride — .2 mg/mL
Dosage form: Injection
Route: Intravenous
Labeler: Somerset Therapeutics, LLCNDC labeler code 70069
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 220243
Marketing start: Apr 20, 2026
Listing expires: Dec 31, 2027
Other FDA classes: Calcium Channel Antagonists (Mechanism)Cytochrome P450 2C19 Inhibitors (Mechanism)Cytochrome P450 2C8 Inhibitors (Mechanism)Cytochrome P450 2D6 Inhibitors (Mechanism)Cytochrome P450 3A4 Inhibitors (Mechanism)Dihydropyridines (Chemical structure)
Identifiers: Product ID 70069-876_035cb7ef-c5d5-4752-8d43-61b8e8420330SPL ID 035cb7ef-c5d5-4752-8d43-61b8e8420330SPL set ID f8b49f59-7a54-425d-9eca-dfa4022a08d1RxCUI 858599, 858603UNII K5BC5011K3UPC 0370069876015, 0370069875018
Pharmacologic class: Dihydropyridine Calcium Channel Blocker

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N470069087610 followed by a unit qualifier and the quantity

Package 70069-0876-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 20, 2026.

Indications (excerpt from the label)

Nicardipine hydrochloride in 0.9% sodium chloride injection is a calcium channel blocker indicated for the short-term treatment of hypertension when oral therapy is not feasible. 1.1 Hypertension Nicardipine hydrochloride in 0.9% sodium chloride injection is indicated for the short-term treatment of hypertension when oral therapy is not feasible or desirable. For prolonged control of blood pressure, transfer patients to oral medication as soon as their clinical condition permits [see Dosage and Administration (2.6) ] .

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 70069-876

What is NDC 70069-876?: 70069-876 is the product NDC for Nicardipine Hydrochloride, Nicardipine hydrochloride .2 mg/mL injection, listed with the FDA by Somerset Therapeutics, LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Nicardipine Hydrochloride.
What is the active ingredient?: Nicardipine hydrochloride.
Who is the labeler?: Somerset Therapeutics, LLC, NDC labeler code 70069. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Nicardipine Hydrochloride?: 43 other product NDCs are listed under this name. See all Nicardipine Hydrochloride NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Nicardipine Hydrochloride NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Nicardipine Hydrochloride	Nicardipine hydrochloride .1 mg/mL	InjectionIntravenous	Fresenius Kabi USA, LLC	65219-296	65219-0296-20
Nicardipine Hydrochloride	Nicardipine hydrochloride .2 mg/mL	InjectionIntravenous	Fresenius Kabi USA, LLC	65219-298	65219-0298-20
Nicardipine Hydrochloride	Nicardipine hydrochloride 20 mg/1	CapsuleOral	Amerisyn LLC	87564-027	87564-0027-90
Nicardipine Hydrochloride	Nicardipine hydrochloride 30 mg/1	CapsuleOral	Amerisyn LLC	87564-028	87564-0028-90
Nicardipine Hydrochloride	Nicardipine hydrochloride .1 mg/mL	InjectionIntravenous	Caplin Steriles Limited	65145-197	65145-0197-10
Nicardipine Hydrochloride	Nicardipine hydrochloride .2 mg/mL	InjectionIntravenous	Caplin Steriles Limited	65145-198	65145-0198-10
Nicardipine Hydrochloride	Nicardipine hydrochloride .1 mg/mL	InjectionIntravenous	Somerset Therapeutics, LLC	70069-875	70069-0875-10
Nicardipine hydrochloride	Nicardipine hydrochloride 2.5 mg/mL	InjectionIntravenous	Lifestar Pharma LLC	70756-686	70756-0686-10
Nicardipine Hydrochloride	Nicardipine hydrochloride 20 mg/1	CapsuleOral	Amici Pharma Inc	69292-620	69292-0620-90
Nicardipine Hydrochloride	Nicardipine hydrochloride 30 mg/1	CapsuleOral	Amici Pharma Inc	69292-621	69292-0621-90

All 44 Nicardipine Hydrochloride NDCs

Other NDCs under ANDA 220243

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 220243
Product	Strength	Form · route	Labeler	Product NDC
Nicardipine Hydrochloride	Nicardipine hydrochloride .1 mg/mL	InjectionIntravenous	Caplin Steriles Limited	65145-197
Nicardipine Hydrochloride	Nicardipine hydrochloride .2 mg/mL	InjectionIntravenous	Caplin Steriles Limited	65145-198
Nicardipine Hydrochloride	Nicardipine hydrochloride .1 mg/mL	InjectionIntravenous	Somerset Therapeutics, LLC	70069-875